Search research articles
Contact Us
Filters
Showing results (11-20 of 304) with videos related to
Page
of 31
Sort By:
BMC Medical Genetics
|
July 29, 2018
Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome
Monique Tremblay, Diane Brisson, Daniel Gaudet
Current Opinion in Endocrinology, Diabetes, and Obesity
|
February 9, 2024
APOC3 siRNA and ASO therapy for dyslipidemia
Jasmine Chebli, Miriam Larouche, Daniel Gaudet
Journal of the Endocrine Society
|
July 21, 2022
Palmar Striated Xanthomas in Clinical Practice
Nathalie Roy, Daniel Gaudet, Diane Brisson
Circulation
|
May 30, 2002
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
Claude Gagné, Daniel Gaudet, Eric Bruckert, et al.
Current Opinion in Lipidology
|
June 14, 2012
Gene therapy for lipoprotein lipase deficiency
Daniel Gaudet, Julie Méthot, John Kastelein
Expert Opinion on Drug Discovery
|
January 25, 2020
Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia
Etienne Khoury, Diane Brisson, Daniel Gaudet
Future Cardiology
|
July 10, 2024
Emerging therapies for refractory hypercholesterolemia: a narrative review
Agnieszka Pawlos, Etienne Khoury, Daniel Gaudet
Journal of Lipids
|
November 26, 2015
Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality
Sylvia Villeneuve, Diane Brisson, Daniel Gaudet
The New England Journal of Medicine
|
January 6, 2021
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply
Daniel Gaudet, Andrea Ruzza, Raul D Santos
Plos One
|
January 21, 2017
Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
Chao Liu, Daniel Gaudet, Yury I Miller
Page
of 31
Search research articles
Search
Showing results (11-20 of 304) with videos related to
Sort By:
Page
of 31
BMC Medical Genetics
|
July 29, 2018
Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome
Monique Tremblay, Diane Brisson, Daniel Gaudet
Current Opinion in Endocrinology, Diabetes, and Obesity
|
February 9, 2024
APOC3 siRNA and ASO therapy for dyslipidemia
Jasmine Chebli, Miriam Larouche, Daniel Gaudet
Journal of the Endocrine Society
|
July 21, 2022
Palmar Striated Xanthomas in Clinical Practice
Nathalie Roy, Daniel Gaudet, Diane Brisson
Circulation
|
May 30, 2002
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
Claude Gagné, Daniel Gaudet, Eric Bruckert, et al.
Current Opinion in Lipidology
|
June 14, 2012
Gene therapy for lipoprotein lipase deficiency
Daniel Gaudet, Julie Méthot, John Kastelein
Expert Opinion on Drug Discovery
|
January 25, 2020
Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia
Etienne Khoury, Diane Brisson, Daniel Gaudet
Future Cardiology
|
July 10, 2024
Emerging therapies for refractory hypercholesterolemia: a narrative review
Agnieszka Pawlos, Etienne Khoury, Daniel Gaudet
Journal of Lipids
|
November 26, 2015
Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality
Sylvia Villeneuve, Diane Brisson, Daniel Gaudet
The New England Journal of Medicine
|
January 6, 2021
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply
Daniel Gaudet, Andrea Ruzza, Raul D Santos
Plos One
|
January 21, 2017
Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
Chao Liu, Daniel Gaudet, Yury I Miller
Page
of 31